Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-Months randomized clinical trial

Alex N. Haas, Gabriel D. De Castro, Tatiana Moreno, Cristiano Susin, Jasim M. Albandar, Rui V. Oppermann, Cassiano K. Rösing

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Aim: To assess the effect of systemic azithromycin as a supplement to scaling and root planing (SRP) in the treatment of aggressive periodontitis (AgP). Material and Methods: Twenty-four individuals (13-26 years old) underwent a plaque control program, and then were treated with SRP. Subjects were assigned randomly into two groups; the test group used 500 mg azithromycin once a day for 3 days, whereas the control group used a placebo. Clinical variables were assessed at baseline, 3, 6, 9, and 12 months. The periodontal status at baseline and 12 months was compared using the Wald test, and adjusting for the effect of clustering of teeth within subjects. Results: There were no significant differences in visible plaque, gingival bleeding, and supragingival calculus between groups throughout the study. Periodontal probing depth (PPD) and clinical attachment level improved significantly from baseline to 12 months in both groups, with the test group showing significantly more reduction in mean PPD compared with controls (2.88 mm versus 1.85 mm, respectively, p=0.025). Subjects administering azithromycin showed a higher percentage of teeth with attachment gain ≥1 mm (81.34 versus 63.63, p=0.037), whereas the controls had higher percentage of teeth with attachment loss ≥1 mm (11.57 versus 2.24, p=0.015). Conclusions: The adjunctive use of azithromycin has the potential to improve periodontal health of young patients with AgP.

Original languageEnglish (US)
Pages (from-to)696-704
Number of pages9
JournalJournal of Clinical Periodontology
Volume35
Issue number8
DOIs
StatePublished - Aug 1 2008

Fingerprint

Aggressive Periodontitis
Azithromycin
Randomized Controlled Trials
Root Planing
Tooth
Calculi
Therapeutics
Cluster Analysis
Placebos
Hemorrhage
Control Groups
Health

Keywords

  • Adolescents/young-adults
  • Antibiotics
  • Azithromycin
  • Periodontal disease
  • Randomized controlled trial

ASJC Scopus subject areas

  • Periodontics

Cite this

Haas, A. N., De Castro, G. D., Moreno, T., Susin, C., Albandar, J. M., Oppermann, R. V., & Rösing, C. K. (2008). Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-Months randomized clinical trial. Journal of Clinical Periodontology, 35(8), 696-704. https://doi.org/10.1111/j.1600-051X.2008.01254.x

Azithromycin as an adjunctive treatment of aggressive periodontitis : 12-Months randomized clinical trial. / Haas, Alex N.; De Castro, Gabriel D.; Moreno, Tatiana; Susin, Cristiano; Albandar, Jasim M.; Oppermann, Rui V.; Rösing, Cassiano K.

In: Journal of Clinical Periodontology, Vol. 35, No. 8, 01.08.2008, p. 696-704.

Research output: Contribution to journalArticle

Haas, AN, De Castro, GD, Moreno, T, Susin, C, Albandar, JM, Oppermann, RV & Rösing, CK 2008, 'Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-Months randomized clinical trial', Journal of Clinical Periodontology, vol. 35, no. 8, pp. 696-704. https://doi.org/10.1111/j.1600-051X.2008.01254.x
Haas, Alex N. ; De Castro, Gabriel D. ; Moreno, Tatiana ; Susin, Cristiano ; Albandar, Jasim M. ; Oppermann, Rui V. ; Rösing, Cassiano K. / Azithromycin as an adjunctive treatment of aggressive periodontitis : 12-Months randomized clinical trial. In: Journal of Clinical Periodontology. 2008 ; Vol. 35, No. 8. pp. 696-704.
@article{53ef7d97804944518924ca52d5942634,
title = "Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-Months randomized clinical trial",
abstract = "Aim: To assess the effect of systemic azithromycin as a supplement to scaling and root planing (SRP) in the treatment of aggressive periodontitis (AgP). Material and Methods: Twenty-four individuals (13-26 years old) underwent a plaque control program, and then were treated with SRP. Subjects were assigned randomly into two groups; the test group used 500 mg azithromycin once a day for 3 days, whereas the control group used a placebo. Clinical variables were assessed at baseline, 3, 6, 9, and 12 months. The periodontal status at baseline and 12 months was compared using the Wald test, and adjusting for the effect of clustering of teeth within subjects. Results: There were no significant differences in visible plaque, gingival bleeding, and supragingival calculus between groups throughout the study. Periodontal probing depth (PPD) and clinical attachment level improved significantly from baseline to 12 months in both groups, with the test group showing significantly more reduction in mean PPD compared with controls (2.88 mm versus 1.85 mm, respectively, p=0.025). Subjects administering azithromycin showed a higher percentage of teeth with attachment gain ≥1 mm (81.34 versus 63.63, p=0.037), whereas the controls had higher percentage of teeth with attachment loss ≥1 mm (11.57 versus 2.24, p=0.015). Conclusions: The adjunctive use of azithromycin has the potential to improve periodontal health of young patients with AgP.",
keywords = "Adolescents/young-adults, Antibiotics, Azithromycin, Periodontal disease, Randomized controlled trial",
author = "Haas, {Alex N.} and {De Castro}, {Gabriel D.} and Tatiana Moreno and Cristiano Susin and Albandar, {Jasim M.} and Oppermann, {Rui V.} and R{\"o}sing, {Cassiano K.}",
year = "2008",
month = "8",
day = "1",
doi = "10.1111/j.1600-051X.2008.01254.x",
language = "English (US)",
volume = "35",
pages = "696--704",
journal = "Journal of Clinical Periodontology",
issn = "0303-6979",
publisher = "Blackwell Munksgaard",
number = "8",

}

TY - JOUR

T1 - Azithromycin as an adjunctive treatment of aggressive periodontitis

T2 - 12-Months randomized clinical trial

AU - Haas, Alex N.

AU - De Castro, Gabriel D.

AU - Moreno, Tatiana

AU - Susin, Cristiano

AU - Albandar, Jasim M.

AU - Oppermann, Rui V.

AU - Rösing, Cassiano K.

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Aim: To assess the effect of systemic azithromycin as a supplement to scaling and root planing (SRP) in the treatment of aggressive periodontitis (AgP). Material and Methods: Twenty-four individuals (13-26 years old) underwent a plaque control program, and then were treated with SRP. Subjects were assigned randomly into two groups; the test group used 500 mg azithromycin once a day for 3 days, whereas the control group used a placebo. Clinical variables were assessed at baseline, 3, 6, 9, and 12 months. The periodontal status at baseline and 12 months was compared using the Wald test, and adjusting for the effect of clustering of teeth within subjects. Results: There were no significant differences in visible plaque, gingival bleeding, and supragingival calculus between groups throughout the study. Periodontal probing depth (PPD) and clinical attachment level improved significantly from baseline to 12 months in both groups, with the test group showing significantly more reduction in mean PPD compared with controls (2.88 mm versus 1.85 mm, respectively, p=0.025). Subjects administering azithromycin showed a higher percentage of teeth with attachment gain ≥1 mm (81.34 versus 63.63, p=0.037), whereas the controls had higher percentage of teeth with attachment loss ≥1 mm (11.57 versus 2.24, p=0.015). Conclusions: The adjunctive use of azithromycin has the potential to improve periodontal health of young patients with AgP.

AB - Aim: To assess the effect of systemic azithromycin as a supplement to scaling and root planing (SRP) in the treatment of aggressive periodontitis (AgP). Material and Methods: Twenty-four individuals (13-26 years old) underwent a plaque control program, and then were treated with SRP. Subjects were assigned randomly into two groups; the test group used 500 mg azithromycin once a day for 3 days, whereas the control group used a placebo. Clinical variables were assessed at baseline, 3, 6, 9, and 12 months. The periodontal status at baseline and 12 months was compared using the Wald test, and adjusting for the effect of clustering of teeth within subjects. Results: There were no significant differences in visible plaque, gingival bleeding, and supragingival calculus between groups throughout the study. Periodontal probing depth (PPD) and clinical attachment level improved significantly from baseline to 12 months in both groups, with the test group showing significantly more reduction in mean PPD compared with controls (2.88 mm versus 1.85 mm, respectively, p=0.025). Subjects administering azithromycin showed a higher percentage of teeth with attachment gain ≥1 mm (81.34 versus 63.63, p=0.037), whereas the controls had higher percentage of teeth with attachment loss ≥1 mm (11.57 versus 2.24, p=0.015). Conclusions: The adjunctive use of azithromycin has the potential to improve periodontal health of young patients with AgP.

KW - Adolescents/young-adults

KW - Antibiotics

KW - Azithromycin

KW - Periodontal disease

KW - Randomized controlled trial

UR - http://www.scopus.com/inward/record.url?scp=47849129519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47849129519&partnerID=8YFLogxK

U2 - 10.1111/j.1600-051X.2008.01254.x

DO - 10.1111/j.1600-051X.2008.01254.x

M3 - Article

C2 - 18631245

AN - SCOPUS:47849129519

VL - 35

SP - 696

EP - 704

JO - Journal of Clinical Periodontology

JF - Journal of Clinical Periodontology

SN - 0303-6979

IS - 8

ER -